Treatment with anti-γ-glutamyl transpeptidase antibody attenuates osteolysis in collagen-induced arthritis mice
Treatment with anti-γ-glutamyl transpeptidase antibody attenuates osteolysis in collagen-induced arthritis mice
复制标题
DOI：
10.1359/jbmr.070726
复制
发表时间：
2007-12-01
影响因子：
6.2
通讯作者：
Niida, Shumpei
中科院分区：
文献类型：
--
作者：
Ishizuka, Yasuyuki;Moriwaki, Sawako;Niida, Shumpei
用CIA小鼠研究了一种新型抗体治疗关节炎相关性骨溶解的有效性。GGT是一种新发现的骨吸收因子，在关节炎关节中上调。我们制备了抗GGT的单克隆抗体，并将其注射到CIA小鼠体内。用抗体治疗的小鼠显示破骨细胞数量和骨侵蚀减少。简介：γ -谷氨酰转肽酶（GGT）作为骨吸收因子，刺激破骨细胞的形成。在炎症部位（如类风湿关节炎）积聚的活跃淋巴细胞中检测到GGT表达。我们假设GGT是抑制关节炎相关破骨细胞生成和关节破坏的有效靶点。在这里，我们用胶原诱导关节炎（CIA）小鼠模型描述了中和抗GGT抗体对关节破坏的治疗效果。材料与方法：采用免疫组织化学和RT-PCR方法检测RA患者和CIA小鼠滑膜中GGT的表达。利用BALB/c小鼠制备了抗重组人GGT单克隆抗体（GGT- mab）。通过向CIA小鼠腹腔注射ggt - mab进行抗体治疗。通过发生率评分、关节炎评分和组织病理学观察来评估抗体治疗对关节炎和骨侵蚀的影响。采用建立的破骨细胞培养体系，探讨GGT在破骨细胞发育中的作用。结果：炎症滑膜中GGT表达明显上调。免疫组化显示GGT存在于淋巴细胞、浆细胞、巨噬细胞和毛细血管中。注射ggt - mab可显著降低CIA小鼠破骨细胞数量，减轻关节破坏程度。体外检测显示GGT促进rankl依赖性破骨细胞的形成。GGT分别刺激成骨细胞中RANKL和破骨细胞前体中RANKL受体的表达。结论：本研究表明，炎症滑膜组织源性GGT是关节破坏的危险因素，抗体介导的GGT抑制可显著减少CIA小鼠的破骨细胞数量和骨侵蚀。GGT拮抗剂可能是减轻RA患者关节破坏的新型治疗药物。
The effectiveness of a new antibody treatment on arthritis-associated osteolysis was studied by using CIA mice. GGT, a newly identified bone-resorbing factor, was upregulated in arthritic joints. We generated monoclonal antibodies against GGT and injected them into CIA mice. Mice treated with antibodies showed a reduction in osteoclast number and bone erosion.Introduction: gamma-Glutamyl transpeptidase (GGT) acts as a bone-resorbing factor that stimulates osteoclast formation. GGT expression has been detected in active lymphocytes that accumulate at inflammation sites, such as rheumatoid arthritis (RA). We hypothesize that GGT is an effective target for suppression of arthritis-related osteoclastogenesis and joint destruction. Here, we describe the therapeutic effect of neutralizing antibodies against GGT on joint destruction using a collagen-induced arthritis (CIA) mouse model.Materials and Methods: GGT expression in the synovium of RA patients and CIA mice was determined by immunohistochemistry and RT-PCR. Monoclonal antibodies were generated against recombinant human GGT (GGT-mAbs) using BALB/c mice. Antibody treatment was performed by intraperitoneal injections of GGT-mAbs into CIA mice. Effects of antibody treatment on arthritis and bone erosion were evaluated by incidence score, arthritis score, and histopathological observations. The role of GGT in osteoclast development was examined by using the established osteoclastogenic culture system.Results: GGT expression was significantly upregulated in inflamed synovium. Immunohistochemistry revealed that GGT was present in lymphocytes, plasma cells, and macrophages, as well as capillaries. Injection of GGT-mAbs significantly decreased the number of osteoclasts and attenuated the severity of joint destruction in CIA mice. In vitro examination showed that GGT enhanced RANKL-dependent osteoclast formation. GGT stimulated the expression of RANKL in osteoblasts and its receptor RANK in osteoclast precursors, respectively.Conclusions: This study indicates that inflamed synovial tissue-derived GGT acts as a risk factor for joint destruction and that the antibody-mediated inhibition of GGT significantly decreases osteoclast number and bone erosion in CIA mice. GGT antagonists might be novel therapeutic agents for attenuating joint destruction in RA patients.